Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05837910 · ClinicalTrials.gov registry record · NA
Radicle Calm 2: A Study of Health and Wellness Products on Feelings of Anxiety, Stress, and Health Outcomes
A NA study, sponsored by Radicle Science.
- Completed
- Registry status
- NA
- Development phase
- 3,853
- Enrollment target
NCT05837910: Completed NA study, sponsored by Radicle Science.
NCT05837910 is a NA study that has completed, run by Radicle Science. The registered enrollment target is 3,853 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (174% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05837910, a NA study, has completed, sponsored by Radicle Science.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,853 participants
- Enrollment target
Study Summary
A randomized, double-blinded, placebo-controlled study assessing the impact of health and wellness products on feeling of anxiety, stress, and other health outcomes
Primary Outcome
Mean difference in feelings of anxiety score as assessed by Patient Reported Outcome Measurement System (PROMIS) Anxiety 8A (scale 8-40; where lower scores correspond to less feelings of anxiety)
Interventions
- DIETARY_SUPPLEMENT Placebo Control Form 1
- DIETARY_SUPPLEMENT Calm Active Study Product 1.1 Usage
- DIETARY_SUPPLEMENT Calm Active Study Product 1.2 Usage
- DIETARY_SUPPLEMENT Calm Active Study Product 1.3 Usage
- DIETARY_SUPPLEMENT Placebo Control Form 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,853 participants |
| Start Date | 2023-04-03 |
| Est. Completion | 2024-04-26 |
| Phase | NA |
What the finished NCT05837910 record still lists
NCT05837910 is an interventional study that assigns participants to a tested intervention. Its 3,853 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (174% higher).
The record links to 0 conditions, and to 5 interventions - of which Placebo Control Form 1 is the first listed.
NCT05837910 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05837910 about?
NCT05837910 is a clinical study titled "Radicle Calm 2: A Study of Health and Wellness Products on Feelings of Anxiety, Stress, and Health Outcomes". A randomized, double-blinded, placebo-controlled study assessing the impact of health and wellness products on feeling of anxiety, stress, and other health outcomes
What is the current status of trial NCT05837910?
This trial is currently completed. It is a NA study. The enrollment target is 3,853 participants. The study started on 2023-04-03. Estimated completion is 2024-04-26.
What interventions are being tested in trial NCT05837910?
The interventions under investigation include: Placebo Control Form 1 (DIETARY_SUPPLEMENT), Calm Active Study Product 1.1 Usage (DIETARY_SUPPLEMENT), Calm Active Study Product 1.2 Usage (DIETARY_SUPPLEMENT), Calm Active Study Product 1.3 Usage (DIETARY_SUPPLEMENT), Placebo Control Form 2 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05837910?
This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05837910's enrollment target sits among peer trials
3,853 36th of 2000 higher than 1,965 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07087613 · 3,850 participants
Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG
- NCT05919342 · 3,904 participants · NA
Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"
- NCT04573660 · 3,784 participants
Abbott Vascular Medical Device Registry
- NCT03936335 · 3,930 participants
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI